Overcoming Isotope Scarcity & Upstream Bottlenecks for Next-Generation Alpha Emitters
- Addressing precursor vulnerabilities and geopolitical constraints impacting Tb-161, At-211 & Pb-212
- Mitigating risks from long-lived isotopic impurities on QC, licensing, and clinical operations
- Scaling production networks through cyclotrons, linear accelerators, and centralized “super-sites” to support commercial demand